In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

True Innovation In Women’s Health Hindered Because Conditions Are Not Fatal

Executive Summary

Drug developers and financiers discuss the biggest challenges delaying novel R&D in diseases effecting only women and how poor awareness of the debilitating symptoms that come with some conditions has led to a lack of emphasis on innovative research.

Advertisement

Related Content

Ferring Plots Genomics Path With Celmatix Pact
AbbVie Prices Oral Endometriosis Drug Orilissa In Value Range, Focusing On Access
Menopausal Symptoms Cooled By KaNDy's Dual Neurokinin Antagonist
Forendo Pharma: Tackling The Endometriosis Challenge

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV123538

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel